Talea Group S.p.a. · MIL:TALEA
Talea — Farmaè — Non-Deal Roadshow (June 2022)
33 slides from Talea's roadshow presentation, Jun 22, 2022
Slide 1: Alantra Roadshow
Alantra Roadshow 22 June 2022
Slide 2: The first true Multi-Channel online player in Europe in the reference Macro Sector
The first true Multi-Channel online player in Europe in the reference Macro Sector
Slide 3: The first true Multi-Channel online player in Europe in the reference Macro Sector
The first true Multi-Channel online player in Europe in the reference Macro Sector Health, Wellness & Pet Beauty Farmaè Group is the undisputed leader in Italy with its online platforms: www.farmae.it, www.amicafarmacia.com, www.farmaeurope.eu. The Group operates in the Beauty market (professional s
Slide 4: The first online player in Italy in the Healthcare, Beauty and Wellness sector
The first online player in Italy in the Healthcare, Beauty and Wellness sector Online development through the integration of the eCommerce model with the Media model 70,000 43,644,905 3.9% 2.5X SKUs* Site Visits Conversion Rate Repeated Order per client 8,512,780 48€ 1,709,406 679,885 Products sold
Slide 5: A retail business that grows steadily
A retail business that grows steadily Thanks to a real omnichannel strategy, the development of a tactical and strategic retail €5.0M 271k 141k +106% +26% +30% Revenues Product sold Number of clients FY2021 in FY2021 in FY2021 Retail Performance FY2021 - Figures include AmicaFarmacia. 5
Slide 6: A results-oriented agency
A results-oriented agency Valnan Revenues at €1.6m* Thanks to an innovative business model in the field of online communication and marketing, Valnan is a point of reference for Italian SMEs of different sectors Valnan Communications is an Online Communication and Marketing agency that offers its cl
Slide 7: From Data Economy to Media
From Data Economy to Media Co-marketing Revenues at €3.4m*, +72% YoY Thanks to the knowledge and transparency of the reading of millions of data Farmaè has become a reference media for the main industries in the sector Farmaè develops partnerships with the main industrial companies in the sector, fr
Slide 8: Technological development to support business
Technological development to support business A company capable of transforming itself into a Tech Company. Constant introduction of technological innovation both in terms of software solutions for business rather than digital platforms to take full advantage of the opportunities of Web 4.0, making
Slide 9: The purchasing experience also through the service
The purchasing experience also through the service The development of the logistic capacity to improve and accelerate the main service lever: delivery Advanced Logistic Hubs to efficiently serve customers Farmaè 5,000 sqm Automated logistics hub located in New warehouse to support growth Migliarino
Slide 10: Sustainability in Farmaè: from saying to doing, a path of awareness
Sustainability in Farmaè: from saying to doing, a path of awareness Farmaè has become carbon neutral: • Identification, through the materiality analysis, of the issues that reflect the significant economic, environmental and social impacts for the Group and that substantially influence the assessmen
Slide 11: A clear long term strategy to consolidate our Market Leadership
A clear long term strategy to consolidate our Market Leadership A continuous strategy of growth organically and through M&A M&A Online Consolidate leadership by enlarging the customer base and Opportunistic acquisitions of high potential leading targets, improving the loyalty of active customers, al
Slide 12: AmicaFarmacia’s acquisition
AmicaFarmacia’s acquisition AmicaFarmacia is the second Italian online player in the Health & Wellness Pharmacy Para - Pharmacy +16% YoY €91m €105m 2020 Pro-forma Revenues* 2021 Pro-forma Revenues* Farmaè + AmicaFarmacia Farmaè + AmicaFarmacia Online Platform www.amicafarmacia.com Synergies Consolid
Slide 13: Successful integration in the first six months
Successful integration in the first six months….and synergies still to be reflected on Group’s account 2 online platforms www.farmae.it and Amicafarmacia Amicafarmacia www.amicafarmacia.com but: March 2021 March 2022 ✓ One single entity Farmaè S.p.A.; ✓ A unique phurchase department with better 2.1
Slide 14: Health and Wellness Market
Health and Wellness Market
Slide 15: Farmaè Group is the undisputed leader on the Italian market
Farmaè Group is the undisputed leader on the Italian market Top 5 players represent the 46% Traffic Share leadership of Market Revenues Farmaè + AmicaFarmacia + Farmaeurope at 59% 125% 97% 99% 100% 100% 92% 82% 75% 75% 62% 55% 50% 46% 25% 0% Top5 Top15 Top 50 Top Other Small Source: IQVIA 2020 Sourc
Slide 16: Italian enlarged competitive scenario
Italian enlarged competitive scenario Generalists and specialized portals must also be considered in the competitive scenario Pharmacies, parapharmacies Generalist portals, Specialized portals and chains marketplaces 16
Slide 17: European Pharmacy Trend
European Pharmacy Trend In other European countries, where prescription drugs are also sold online, the share of online reaches 18%, as in Germany Legislation 2,5 bn€ 398 mln€ 17
Slide 18: Our consumers
Our consumers The pandemic event in progress has radically changed the purchasing propensity of the final customer
Slide 19: Customer Care
Customer Care We are close to our customers through an effective and efficient customer care, able to support customers during all purchasing phases. 30 8 5 People in the team Consultants Different lines 1.500 calls per day Before purchasing During the purchase phase After purchasing The customer ne
Slide 20: Trustpilot Reviews
Trustpilot Reviews 334.575 Certified Reviews 20
Slide 21: Consumer Health&Pharma: Italian online buyers
Consumer Health&Pharma: Italian online buyers 18 Million users purchased a Health&Pharma product online at least once in 2021 100% 28.5 million individuals Online Buyers: 28.5 million Online buyers of products Total online buyers of both 95.6% products and services and 27.2 million individuals Onlin
Slide 22: Consumer Health&Pharma: online buyers
Consumer Health&Pharma: online buyers The choice of the retailer is driven by prior knowledge and research on the WEB. The search engine is the first purchase driver in the product information retrieval phase. Word of mouth and advice from non-healthcare professionals are increasingly relevant drive
Slide 23: Financials
Financials +FARMAEGROUP
Slide 24: Update on 1Q2022 KPIs
Update on 1Q2022 KPIs Like for like figures including in 1Q2021 Amicafarmacia KPIs Site Visits (m) Product sold (m) CAGR CAGR 2016-2021 2016-2021 +68.2% +86.7% +15% Orders (m) Active customers (k) Conversion Rate (%)* CAGR 2016-2021 +9.4% +15% +21.3% CAGR 2016-2021 +103.1% +14% *1Q2022 conversion ra
Slide 25: Main Financial Highlights
Main Financial Highlights 2021 first time adoption of IFRS accounting standard Revenues (€/m) Marketing & Distribution expenses (€/m) +40% Italian GAAP IFRS EBITDA Adj Net Profit (€/m) (€/m) Italian GAAP IFRS Italian GAAP IFRS *2021 consolidated results include 3 months revenues of AmicaFarmacia & M
Slide 26: Solid Balance Sheet
Solid Balance Sheet 2021 first time adoption of IFRS accounting standard Net Working Capital (€/m) Net Financial Position (€/m) 14.1 3.3 Italian GAAP IFRS 26
Slide 27: Appendix
Appendix
Slide 28: A unique history of growth
A unique history of growth The growth speed is the main driver for a successfull positioning AmicaFarmacia Beautyè acquisition Listed on the Launch Opening of offline AIM Market 2020 stores in Tuscany €65.5m 2018 2016 €24,9m €7.6m 2014 2021 2019 2019 €85.9m 2017 €37.5m 2015 €13.3m New Logistic Reven
Slide 29: Governance
Governance BOARD OF DIRECTORS STOCK FIGURES Riccardo Iacometti Outstanding shares 6,846,270 Market EGM Chairman & CEO post-IPO Free Float 28.04% Date IPO July 29, 2019 Marco Di Filippo Giuseppe Cannarozzi Market Cap (17/06/2022) € 101.6m Alberto Maglione Issue Price (€) € 7.50 Director General Manag
Slide 30: Profitability improves
Profitability improves 2021 first consolidated financial statement and IFRS adoption 2021 vs. 2020 • First consolidated financial statement in 2021 under IFRS Accounting Standard and the relative €/mln 2021 2020 YOY comparative period Sales 82.5 64.1 28.7% • 2021 consolidated results include 3 month
Slide 31: FY 2021 Revenues split
FY 2021 Revenues split Revenues (€/m) Pro-forma Revenues (€/m) +40% +16% Online (€/m) Retail (€/m) Consultancy - Valnan (€/m) *2021 consolidated results include 3 months revenues of AmicaFarmacia & Madonna della Neve pharmacy, and Valnan Revenues for 1,6 m 31
Slide 32: Disclaimer
Disclaimer “This Presentation contains certain forward-looking statements. Forward-looking statements concern future circumstances and results and other statements that are not historical facts, sometimes identified by the words "believes," "expects," "predicts," "intends," "projects," "plans," "est
Slide 33: Thank You
Thank You +FARMAECROUP